Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200065474Phase 4Recruiting
Phase 4, randomised trial of ciprofol in gynaecological conditions, genitourinary diseases (GU) and musculoskeletal condition (MSK) (2 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoints: Injection pain, Time to MOAA/S ≤ 1 and 6 more. Started Dec 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200065474.